In summary, these findings are in good accordance with previously published data [32,33] and indicate that diosmetin can alleviate the pathophysiological and hematological changes associated with AD, prevent hyperkeratosis of the skin, and maintain hydration function by increasing LEKTI expression and inhibiting the activation and expression of KLK5. The gene discussed is KLK5; the disease is Alzheimer disease.